Table 2.
Relationship between Stabilin-2 expression and clinicopathological parameters
| Variable | Low expression of Stabilin-2 | High expression of Stabilin-2 | P value |
|---|---|---|---|
| Age, year | 0.042 | ||
| <60 | 35 | 19 | |
| ≥60 | 23 | 28 | |
| Pathologic subtype | 0.773 | ||
| Adenocarcinoma | 41 | 32 | |
| Other* | 17 | 15 | |
| Gender | 0.539 | ||
| Male | 44 | 38 | |
| Female | 14 | 9 | |
| Smoking | 0.103 | ||
| No | 17 | 21 | |
| Yes | 41 | 26 | |
| T stage | 0.274 | ||
| 1–2 | 45 | 32 | |
| 3–4 | 13 | 15 | |
| N status | 0.042 | ||
| Negative | 35 | 19 | |
| Positive | 23 | 28 | |
| TNM stage | 0.126 | ||
| I–II | 37 | 23 | |
| III–IV | 21 | 24 | |
| Adjuvant chemotherapy | 0.979 | ||
| Yes | 31 | 25 | |
| No | 27 | 22 |
*:squamous carcinoma; bronchioloalveolar carcinoma; and adeno-squamous carcinoma.